Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era

Liset Olarte, William J. Barson, John S. Bradley, Tina Quanbee Tan, Philana Ling Lin, José R. Romero, Laurence B. Givner, Jill A. Hoffman, Kristina G. Hultén, Edward O. Mason, Sheldon L. Kaplan

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

We identified 53 infants aged 0-60 days with invasive pneumococcal disease (IPD) at 8 children's hospitals in the United States (2005-2015). After the introduction of 13-valent pneumococcal conjugate vaccine (PCV13), IPD caused by PCV13 serotypes decreased ~30% providing some evidence of indirect protection. However, approximately 60% of IPD was still caused by PCV13 serotypes.

Original languageEnglish (US)
Pages (from-to)249-252
Number of pages4
JournalJournal of the Pediatric Infectious Diseases Society
Volume7
Issue number3
DOIs
StatePublished - Aug 17 2018

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era'. Together they form a unique fingerprint.

Cite this